Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly those targeting cyclin-dependent kinases (CDKs). Its structure supports the development of compounds with antitumor and antiviral activities. Commonly employed in medicinal chemistry for optimizing lead compounds due to its favorable binding properties and scaffold rigidity. Also explored in the design of selective inhibitors for neurodegenerative disease targets.